Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Earlier and worse strokes tied to heavy drinking

Written by | 6 Nov 2025

Researchers report that people drinking three or more alcoholic drinks per day are at a significantly greater risk of intracerebral hemorrhage (a type of stroke caused by bleeding… read more.

One drug offers hope for stroke patients

Written by | 18 Jul 2025

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led… read more.

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

Written by | 5 Jul 2025

New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm and future health conditions, even in… read more.

New approach to post-stroke aphasia emerges

Written by | 28 Jun 2025

Researchers report that in patients with chronic aphasia after stroke, right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy… read more.

More people now die at home after stroke than in medical facilities

Written by | 15 Apr 2025

A new analysis finds a significant uptick in the number of people dying at home due to ischemic stroke compared to inpatient medical facilities, and when not at… read more.

Could vaping be linked to spinal cord infarct?

Written by | 1 Apr 2025

29th EAHP Congress highlights Cigarette smoking is a well-recognised risk factor for stroke and measures to reduce the prevalence of cigarette smoking have been implemented in many countries…. read more.

Combination statin and ezetimibe could be a life-saver for high-risk patients

Written by | 25 Mar 2025

Patients at high risk of heart attack and stroke should be treated with a combination of a statin and ezetimibe, and as soon as possible, researchers have concluded… read more.

FDA approves TNKase (tenecteplase) in acute ischemic stroke in adults – Genentech/ Roche

Written by | 13 Mar 2025

Genentech, a member of the Roche Group  announced that the  FDA  has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS)… read more.

NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes

Written by | 11 Mar 2025

The NHS could prevent thousands more heart attacks and strokes every year by offering everyone in the UK aged 50 and over a single “polypill” combining a statin… read more.

New study adds to evidence of stroke and heart attack risk with some hormonal contraceptives

Written by | 21 Feb 2025

Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark in The BMJ today that draws on prescription records to give… read more.

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Written by | 19 Feb 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart… read more.

Heart disease remains leading cause of death as key health risk factors continue to rise

Written by | 3 Feb 2025

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.